ALS clinical trials: How stem cells could fuel biomarker development
BrainStorm is generating stem cells to test its ALS drug in a genetic subpopulation after missing the mark in a Phase III trial.
Stay updated with breaking news from Centric Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BrainStorm is generating stem cells to test its ALS drug in a genetic subpopulation after missing the mark in a Phase III trial.
Even if enrollment hiatus is lifted, logistical issues such as sending samples to and from Russia another setback.
HiberCell has commenced a first-in-human Phase Ia/b clinical trial of HC-7366 to treat advanced solid tumour patients.
Apart from gastric cancer, we also review Regenxbio in mucopolysaccharidosis type I and four Phase I trial updates.
Resverlogix has expanded the Phase IIb clinical trial for analysing apabetalone (RVX-208) as a potential oral Covid-19 therapy to Brazil.